Form 4: Medpace CEO August J. Troendle Sells Shares
SEC Form 4 Filing
Medpace Holdings CEO August J. Troendle sold 4,020 shares of common stock at a weighted average price of $400.19 on May 20, 2024.
Summary
- On May 20, 2024, August J. Troendle, CEO of Medpace Holdings, Inc., sold 4,020 shares of common stock.
- The sale was executed at a weighted average price of $400.19 per share, with individual transactions ranging from $400.00 to $400.50.
- Following the transaction, Troendle directly owns 664,393 shares and indirectly owns 4,733,019 shares through Medpace Investors, LLC.
- The sale was conducted under a limit order placed during an open window period.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock sale by an executive. No specific positive or negative implications can be derived without further context.
Industry Context
This is a routine Form 4 filing, disclosing the sale of shares by a company insider. Such filings are common and provide transparency into the trading activities of company executives and directors.
Stakeholder Impact
- The stock sale by the CEO could be perceived neutrally or slightly negatively by shareholders, depending on the context and reasons for the sale.
Key Dates
| Date | Description |
|---|---|
| 05/20/2024 | Date of the stock sale transaction |
| 05/22/2024 | Date of the signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.